ABILIFY ASIMTUFII vs INVEGA HAFYERA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Possible drug interaction. ABILIFY ASIMTUFII and INVEGA HAFYERA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	ABILIFY ASIMTUFII	INVEGA HAFYERA
Rating	New	70/100
Pharmacy pays	$0.13 /mL	—
Type	RX	RX
Active ingredient	ARIPIPRAZOLE	PALIPERIDONE PALMITATE
Manufacturer	Otsuka	Janssen Pharms
Dosage forms	Injectable	Injectable
Drug class	Atypical Antipsychotic	Atypical Antipsychotic
Boxed warning	Boxed warning	Boxed warning
Half-life	about 75 hours (mean elimination half-life of the parent drug in typical adults)	—
Treats	Schizophrenia	Bipolar Disorder, Depressive Disorder, Schizophrenia

abilify asimtufii invega hafyera

Rating

New

70/100

Pharmacy pays

$0.13 /mL

—

Type

Active ingredient

ARIPIPRAZOLE

PALIPERIDONE PALMITATE

Manufacturer

Otsuka

Janssen Pharms

Dosage forms

Injectable

Drug class

Atypical Antipsychotic

Boxed warning

Half-life

about 75 hours (mean elimination half-life of the parent drug in typical adults)

—

Treats

Schizophrenia

Bipolar Disorder, Depressive Disorder, Schizophrenia

Frequently asked questions

What is the difference between Abilify Asimtufii and Invega Hafyera?

Abilify Asimtufii contains Aripiprazole, while Invega Hafyera contains Paliperidone Palmitate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.